Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

MyVobo 0.3 M Tablet SR

Prescription Icon
Prescription Required

Marketer

Mylan Pharmaceuticals Pvt Ltd - A Viatris Company

Salt Composition

Metformin (500mg) + Voglibose (0.3mg)

Overview MyVobo 0.3 M Tablet SR

DiaBetaComb 0.3mg Extended-Release tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adult patients. It helps regulate blood glucose levels. DiaBetaComb 0.3mg Extended-Release tablets should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage will be determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar or feeling well. Discontinuing treatment without physician consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Possible side effects include nausea, altered taste perception, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes; these are usually transient and self-limiting. Persistent or concerning side effects warrant immediate medical attention. Your doctor can offer strategies to manage or treat bothersome side effects. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of MyVobo 0.3 M Tablet SR

No information provided. A rephrased version cannot be created.

Uses of MyVobo 0.3 M Tablet SR

Managing type 2 diabetes

Major Benefits of MyVobo 0.3 M Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for MyVobo 0.3 M Tablet SR. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

Common Side effects of MyVobo 0.3 M Tablet SR:

  • Flatulence
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Decreased appetite

How to use MyVobo 0.3 M Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the MyVobo 0.3 M Tablet SR whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

How MyVobo 0.3 M Tablet SR works:

MyVobo SR 0.3mg tablets contain a dual-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining MyVobo 0.3 M Tablet SR and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using MyVobo 0.3 M Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of MyVobo 0.3 M Tablet SR while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Driving ability is generally unaffected by MyVobo 0.3 M Tablet SR. Nevertheless, patients taking this medication concurrently with other antidiabetic medications, including sulfonylureas, insulin, or repaglinide, should be aware of the potential for low blood sugar.

KidneyKidneyCAUTION

Patients with kidney impairment should use MyVobo 0.3 M Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Routine monitoring of renal function is recommended during treatment.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding MyVobo 0.3 M Tablet SR use in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take MyVobo 0.3 M Tablet SR :

Should you forget a MyVobo 0.3 M Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About MyVobo 0.3 M Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
MyVobo 0.3 M Tablet SR
62
MRP 72
13% off